Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
about
Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and ChallengesLarge animal models of cardiovascular diseaseCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityUrine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.Physical performance and protein-energy wasting in patients treated with nocturnal haemodialysis compared to conventional haemodialysis: protocol of the DiapriFIT studySerum sclerostin is an independent predictor of mortality in hemodialysis patientsTreatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism.Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.Sclerostin and CKD-MBD.From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans.Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients.Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.Sclerostin as a new key player in arteriovenous fistula calcification.Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments.Serum sclerostin: relation with mortality and impact of hemodiafiltration.Bone markers and cardiovascular risk in type 2 diabetes patients.Bisphophonates in CKD patients with low bone mineral density.Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.Circulating levels of sclerostin are associated with cardiovascular mortality.TGF-Beta Signaling in Bone with Chronic Kidney DiseaseVascular calcification and renal bone disorders
P2860
Q26744599-6A1AE04A-570C-4094-8F51-F6B03C46801EQ26766350-3499B6C4-0931-4AE2-9F62-26E285B1BB95Q28081407-D1150CEE-13A9-4091-ADAF-723A60F71A34Q33559001-AE94EC7F-3B12-4B23-80CB-2C54C16841C0Q33623543-152F2787-A02B-4A42-9297-3806E9DDE154Q34695045-E27CF8DF-6BE0-460B-891A-B6A0FD62BA49Q36193227-803BC6EB-CF33-4175-9B9A-71B1B0018C19Q36306725-EC728C9A-55DB-433B-8D6C-76ED8A6A7FD1Q38359423-688CFCE3-290B-4F06-B847-D87B52871C53Q38367220-B3B750AE-6E7E-4BBF-9420-A077D9AA9A7BQ38569480-3134C0CD-4A60-4C24-B273-BB6077D95428Q38687054-C882E079-F5D9-4CAC-98A7-4985A2CF04CDQ38920636-4A0C618E-A9C8-4E0F-B49B-24946FE3525EQ38955348-78F2E423-DF4D-4EF7-A7A5-79510A9EB2B4Q39552618-262B750F-1568-4D93-A7BE-370777D1FC19Q40760789-A75E7F20-7D51-423F-9634-994CC43362FBQ45755917-9E808B61-B048-4C1D-AECB-EC6A8D30E1EAQ47630210-28A349C4-09FE-49EF-9826-34296B019C40Q49719211-03CC2454-D5BA-4065-B034-2312840AA217Q51679309-4517B8D3-5F77-4AB3-8A8C-7649E8970D73Q51762210-CB33B95A-44DF-4D9E-8839-0A6D24F20B26Q53073924-B2CAB4F2-E8CC-4CA1-ADBC-200776F0016EQ53738261-AA57D4DB-7A39-4683-BE67-D8570E36079AQ54313739-61401598-B77E-47A5-BB4B-FBED5DC2DAADQ55026099-CC7855FE-BE78-4FD0-82E1-E1CB52B0B58EQ55496723-000657DC-C43B-4F41-955D-D73CB76239ECQ58789309-9DB75575-E64A-4EA8-BC5E-2862116F66D3Q59100578-0472D70A-D98A-409C-97BB-E26BB45E5865
P2860
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@en
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@nl
type
label
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@en
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@nl
prefLabel
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@en
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@nl
P2093
P2860
P356
P1476
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
@en
P2093
Franck Blocki
Kathleen Claes
Liesbeth Viaene
Patrick C D'Haese
Pieter Evenepoel
Vincent Brandenburg
P2860
P304
P356
10.1093/NDT/GFT039
P407
P577
2013-04-19T00:00:00Z